INS and type 2 diabetes mellitus: The patients in the LRYGB group had more severe T2DM, with a median T2DM duration of 4.5 years (IQR 9.0), and a mean number of anti-diabetic medications of 1.69 (SD 1.16), with 39% of them requiring insulin.